Searchable abstracts of presentations at key conferences in endocrinology

ea0063p939 | Diabetes, Obesity and Metabolism 3 | ECE2019

Prevalence and predictive factors of advanced fibrosis in type 2 diabetic patient in a majoritally abstinent population of alcohol

Fennoun Halima , El Mansouri Souhaila , Tahiri Mohamed , El Aziz Siham , Haddad Farid , Hliwa Wafaa , Badr Wafa , Chadli Asma

Introduction: Metabolic steatopathy is frequently associated with type 2 diabetes, which may progress to advanced fibrosis. The objectives of this study were to evaluate the prevalence and predictors of the severity of hepatic impairment in this population.Methods: A cross-sectional study involving 281 type 2 diabetic patients followed in the endocrinology department in collaboration with the Hepato-Gastroenterology department of Ibn Rochd University Hos...

ea0063p949 | Diabetes, Obesity and Metabolism 3 | ECE2019

Detection of metabolic hepatic steatosis in type 2 diabetic patient: about 281 cases

Fennoun Halima , Mansouri Souhaila El , Tahiri Mohamed , Aziz Siham El , Haddad Farid , Hliwa Wafaa , Badr Wafa , Chadli Asma

Introduction: Metabolic liver steatosis is frequently associated with type 2 diabetes with an increased risk of progression to advanced fibrosis. Objective of this study was to estimate the prevalence of hepatic steatosis in patients with type 2 diabetes.Methods: A cross-sectional study including 281 type 2 diabetic patients followed at the Department of Endocrinology in collaboration with the Hepato-Gastroenterology Department of Ibn Rochd University Ho...

ea0063p953 | Diabetes, Obesity and Metabolism 3 | ECE2019

Hepatic steatosis and cardiovascular risk in diabetic patient type 2

Fennoun Halima , Mansouri Souhaila El , Tahiri Mohamed , Aziz Siham El , Haddad Farid , Hliwa Wafaa , Badr Wafa , Chadli Asma

Introduction: Metabolic hepatic steatosis is a common condition in patients with type 2 diabetes, increasing the risk of cardiovascular morbidity and mortality in the absence of early and adequate management. The objective of this study was to evaluate cardiovascular risk in this population by comparing it with diabetic patients without fatty liver disease.Methods: We conclucted a cross-sectional study including 281 type 2 diabetics followed in Endocrino...